Imaging Study of Chronic Low Back Pain in Patients Taking Pain Medication
Trial ID or NCT#
NCT00388414
Status
NOT RECRUITING
Purpose
Duloxetine has recently been shown to be effective in reducing the pain in chronic pain patients. Duloxetine is known to exert a central mechanism, however the precise human brain structures responsible for mediating its pain-relieving properties are not known. We will use functional magnetic resonance imaging (FMRI) to investigate the neural and functional correlates of pain.
Official Title
Functional MRI Neural Correlates of Medication Efficacy in Patients With Chronic Low Back Pain
Eligibility Criteria
Ages Eligible for Study: 18 Years to 60 Years
Sexes Eligible for Study: Male
Accepts Healthy Volunteers: No
Inclusion Criteria:
- - Males aged 18-60 - Back Pain - Must be able to comply with study visit schedule and other study requirements - Capable of performing the experimental tasks
Exclusion Criteria:
- - Contraindications for MRI examination (e.g., metallic implants such as pacemakers, surgical aneurysm clips, or known metal fragments embedded in the body) - Known hypersensitivity to duloxetine or any of the inactive ingredients - Uncontrolled narrow-angle glaucoma
Investigator(s)
Sean Mackey, M.D., Ph.D.
Pain management specialist,
Pain management specialist,
Anesthesiologist
Redlich Professor, Professor of Anesthesiology, Perioperative, and Pain Medicine and, by courtesy, of Neurology
Contact us to find out if this trial is right for you.
Contact
Neil Chatterjee
6507240522
View on ClinicalTrials.gov
